---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-033705"
form_type: "8-K"
ticker: "LIXT"
cik: "0001335105"
company_name: "LIXTE BIOTECHNOLOGY HOLDINGS, INC."
filed_at: "2024-08-23T23:59:59+00:00"
generated_at: "2026-05-31T07:48:40.076954+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Lixte Biotechnology receives Nasdaq deficiency notice for stockholders' equity requirement

## Summary
- Received Notice from Nasdaq on August 19, 2024 for non-compliance with Listing Rule 5550(b)(1) requiring minimum $2,500,000 stockholders' equity.
- Company has 45 days to submit a plan to regain compliance; Nasdaq may grant up to 180-day extension.
- If plan not accepted or compliance not regained, Company can request hearing which stays suspension or delisting.
- Trading on Nasdaq continues under symbols LIXT and LIXTW with no immediate effect.
- Company intends to take reasonable measures but no assurance of regaining compliance with continued listing standards.

## SEC filing metadata
- accession: 0001493152-24-033705
- form_type: 8-K
- ticker: LIXT
- cik: 0001335105
- company_name: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- filed_at: 2024-08-23T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1335105/000149315224033705/0001493152-24-033705-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1335105/000149315224033705/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-033705
- JSON: https://secwatch.observer/filing/0001493152-24-033705.json
- Plain text: https://secwatch.observer/filing/0001493152-24-033705.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.